Pediatric HIV/AIDS and the skin: an update.
In 2005 there were 2.1 million children under the age of 15 years living with HIV in sub-Saharan Africa. As in the adult pandemic, attendant skin disease is prevalent in children. This article provides an update of pediatric HIV/AIDS and its cutaneous manifestations from four main aspects: epidemiology, skin disease as an indicator of immune status, immune reconstitution inflammatory syndrome, and the impact of antiretroviral agents on skin disease.
Gottschalk
Gavin M
GM
Division of Dermatology, Red Cross Children's Hospital and the University of Cape Town, Klipfontein Road, Rondebosch, Cape Town, 7700, South Africa. gavgott@ich.uct.ac.za
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D002648:Child; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D012871:Skin Diseases / Q000150:complications* / Q000175:diagnosis / Q000276:immunology / Q000473:pathology
D044966:Anti-Retroviral Agents